Table 1. Baseline and Other Characteristics of the Study Participants.
| No. (%) | ||
|---|---|---|
| Azithromycin | Placebo | |
| All birthing parents | 5802 | 5823 |
| Country | ||
| The Gambia | 3210 (55.3) | 3232 (55.5) |
| Burkina Faso | 2592 (44.7) | 2591 (44.5) |
| Age, median (IQR), y | 27.0 (22.0-31.0) | 26.0 (22.0-31.0) |
| Delivery in dry season (Nov-May) | 3776 (65.1) | 3794 (65.2) |
| Cesarean delivery | 118/5800 (2.0) | 115/5821 (2.0) |
| Multiple pregnancy | ||
| Singleton | 5680/5800 (97.9) | 5732/5823 (98.4) |
| Twin | 119/5800 (2.1) | 90/5823 (1.5) |
| Triplet | 1/5800 (0.02) | 1/5823 (0.02) |
| Hours from membrane rupture to delivery, median (IQR) [No.] | 0.3 (0.1-1.5) [3453] | 0.3 (0.1-1.4) [3459] |
| Hours from treatment to delivery, median (IQR) [No.] | 1.6 (0.5-4.0) [5622] | 1.6 (0.5-4.3) [5638] |
| All newborns | 5889 | 5894 |
| Sex | ||
| Female | 2871 (48.8) | 2832 (48.0) |
| Male | 3018 (51.2) | 3062 (52.0) |
| Apgar scorea | ||
| 0-3 | 37/5875 (0.6) | 31/5888 (0.5) |
| 4-7 | 361/5875 (6.1) | 406/5888 (6.9) |
| 8-10 | 5477/5875 (93.2) | 5451/5888 (92.6) |
| Birth weight, kg | ||
| <1.5 | 10/5885 (0.2) | 15/5893 (0.3) |
| 1.5-2.4 | 550/5885 (9.3) | 532/5893 (9.0) |
| 2.5-3.9 | 5198/5885 (88.3) | 5235/5893 (88.8) |
| ≥4.0 | 127/5885 (2.2) | 111/5893 (1.9) |
| Birth weight, median (IQR), kg | 3.0 (2.7-3.3) | 3.0 (2.7-3.3) |
a
The Apgar score is a measure of intrapartum asphyxia (0-3: severe asphyxia, 4-7: mild to moderate asphyxia, and 8-10: no asphyxia).